Keith Martin (ophthalmologist): Difference between revisions
KolbertBot (talk | contribs) m Bot: HTTP→HTTPS (v485) |
m Bot: link syntax |
||
| (15 intermediate revisions by 11 users not shown) | |||
| Line 1: | Line 1: | ||
{{EngvarB|date=June 2014}} |
{{EngvarB|date=June 2014}} |
||
{{Use dmy dates|date=June 2014}} |
{{Use dmy dates|date=June 2014}} |
||
'''Keith Martin''' {{ |
'''Keith Martin''' {{post-nominals|country=GBR|MA}} [[BM BCh]] [[Doctor of Medicine|DM]] [[Membership of the Royal College of Physicians|MRCP]] [[List of post-nominal letters (United Kingdom)|FRCOphth]] [[London College of Music Examinations|ALCM]] is an [[eye care professional|ophthalmologist]]. |
||
He is the inaugural [[Professor]] of [[Ophthalmology]] at the [[University of Cambridge]] and a |
He is the inaugural [[Professor]] of [[Ophthalmology]] at the [[University of Cambridge]] and a specialist in the treatment of [[glaucoma]]. In 2013, Professor Martin's team tested a novel technique of [[bio-printing]], using an [[ink-jet printing|ink jet]] to recreate layers of [[ganglion]] and [[glial]] cells from a rat's [[retina]], a process that has been described as 'printing eyeballs'. |
||
[[File:Retinal cell in jet.png|thumb|upright|Retinal cells within a drop being sprayed from an inkjet nozzle]] |
[[File:Retinal cell in jet.png|thumb|upright|Retinal cells within a drop being sprayed from an inkjet nozzle]] |
||
| Line 15: | Line 15: | ||
In 2009 he became Cambridge University's [[Professor]] of Ophthalmology. This was a new chair, sponsored by the Cambridge Eye Trust.<ref>{{citation |url=http://www.cambridgeeyetrust.org.uk/whatwedo.html |publisher=Cambridge Eye Trust |title=What We Do |year=2012}}</ref> |
In 2009 he became Cambridge University's [[Professor]] of Ophthalmology. This was a new chair, sponsored by the Cambridge Eye Trust.<ref>{{citation |url=http://www.cambridgeeyetrust.org.uk/whatwedo.html |publisher=Cambridge Eye Trust |title=What We Do |year=2012}}</ref> |
||
In 2013, he worked with Dr Barbara Lorber and others on the use of a [[piezoelectric]] inkjet nozzle to spray [[ganglion]] and [[glial]] cells from a rat [[retina]].<ref>{{citation |
In 2013, he worked with Dr Barbara Lorber and others on the use of a [[piezoelectric]] inkjet nozzle to spray [[ganglion]] and [[glial]] cells from a rat [[retina]].<ref>{{citation |title=Adult rat retinal ganglion cells and glia can be printed by piezoelectric inkjet printing |journal=Biofabrication |volume=6 |issue=1 |pages=015001 |doi=10.1088/1758-5082/6/1/015001 |pmid=24345926 |author1=Barbara Lorber |author2=Wen-Kai Hsiao |author3=Ian M Hutchings |author4=Keith R Martin |date=17 December 2013|doi-access=free }}</ref> The cells survived the process of deposition in layers and continued to grow in culture. With further development and testing, techniques like this could have clinical application for the repair of damaged retinas.<ref>{{citation |url=https://www.bbc.co.uk/news/health-25405542 |title=Scientists 'print' new eye cells |author=Michelle Roberts |publisher=BBC |date=18 December 2013|accessdate=16 June 2014}}</ref><ref>{{citation |journal=ShortList |date=29 May 2014 |title=The Man Who Prints Eyeballs}}</ref> |
||
In 2018, Keith became president of the World Glaucoma Association (WGA), the world's largest glaucoma association. |
|||
In 2019, Martin moved to Melbourne where he became the Managing Director for the [https://www.cera.org.au/ Centre for Eye Research Australia] (CERA) and the head of Ophthalmology at the [[University of Melbourne]]. |
|||
==Family life== |
==Family life== |
||
Keith Martin is married and has three children. He lives in |
Keith Martin is married and has three children. He lives in Melbourne.<ref name=RSA/> His wife, Susie, is better known as Dr. Susan Harden, the thoracic oncologist and Lead Clinician in Lung Cancer at [[Addenbrooke Hospital]] before moving to Australia in late 2019 |
||
.<ref name=RSA/> |
|||
==Honours and awards== |
==Honours and awards== |
||
2010: ARVO [[Pfizer| Pfizer Ophthalmics]] [[Carl B. Camras|Carl Camras]] [[Translational Research]] (TR) Award, or 'ARVO Camras Award for TR'. This is an award for young researchers with innovative work that shows potential for clinical application.<ref>{{citation |url=http://www.arvo.org/foundation/Awards_and_Grants/Recipient_history/ |title=Pfizer Ophthalmics Carl Camras Translational Research Awards |publisher=ARVO Foundation for Eye Research|year=2010}}</ref> |
2010: ARVO [[Pfizer| Pfizer Ophthalmics]] [[Carl B. Camras|Carl Camras]] [[Translational Research]] (TR) Award, or 'ARVO Camras Award for TR'. This is an award for young researchers with innovative work that shows potential for clinical application.<ref>{{citation |url=http://www.arvo.org/foundation/Awards_and_Grants/Recipient_history/ |title=Pfizer Ophthalmics Carl Camras Translational Research Awards |publisher=ARVO Foundation for Eye Research |year=2010 |access-date=7 June 2014 |archive-url=https://web.archive.org/web/20150814082509/http://www.arvo.org/foundation/Awards_and_Grants/Recipient_history/ |archive-date=14 August 2015 |url-status=dead }}</ref> |
||
==Publications== |
==Publications== |
||
*{{citation |title=Mechanisms of Retinal Ganglion Cell Death in Glaucoma: New Approaches to the Pathogenesis and Treatment of the Silent Thief of Sight |author=Keith Martin |publisher=VDM Publishing |year=2009 |isbn=9783639161656}} |
*{{citation |title=Mechanisms of Retinal Ganglion Cell Death in Glaucoma: New Approaches to the Pathogenesis and Treatment of the Silent Thief of Sight |author=Keith Martin |publisher=VDM Publishing |year=2009 |isbn=9783639161656}} |
||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
==References== |
==References== |
||
| Line 32: | Line 42: | ||
*[http://www.neuroscience.cam.ac.uk/directory/profile.php?kmartin1 profile] at the Department of Clinical Neurosciences |
*[http://www.neuroscience.cam.ac.uk/directory/profile.php?kmartin1 profile] at the Department of Clinical Neurosciences |
||
{{Authority control}} <!--FYI: there is an authority record for this person in the LC NAF under: no2018014316 --> |
|||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
{{DEFAULTSORT:Martin, Keith}} |
{{DEFAULTSORT:Martin, Keith}} |
||
[[Category:Living people]] |
[[Category:Living people]] |
||
[[Category:20th-century births]] |
[[Category:20th-century births]] |
||
[[Category:Year of birth missing (living people)]] |
|||
[[Category:Alumni of St Catharine's College, Cambridge]] |
[[Category:Alumni of St Catharine's College, Cambridge]] |
||
[[Category:Alumni of the University of Oxford]] |
[[Category:Alumni of the University of Oxford]] |
||
[[Category:Academics of the University of Cambridge]] |
[[Category:Academics of the University of Cambridge]] |
||
[[Category:British ophthalmologists]] |
[[Category:British ophthalmologists]] |
||
[[Category:People educated at The Royal School, Armagh]] |
|||
Revision as of 19:33, 25 May 2024
Keith Martin BM BCh DM MRCP FRCOphth ALCM is an ophthalmologist.
He is the inaugural Professor of Ophthalmology at the University of Cambridge and a specialist in the treatment of glaucoma. In 2013, Professor Martin's team tested a novel technique of bio-printing, using an ink jet to recreate layers of ganglion and glial cells from a rat's retina, a process that has been described as 'printing eyeballs'.
Early life and education
Martin was educated at The Royal School, Armagh, from 1980 to 1987, and was head boy in his final year.[1] He then won a place at St Catharine's College, Cambridge to read medical science and neuroscience. He graduated with first class honours in three subjects.[1]
He qualified as a medical doctor at Oxford University in 1993. He then did medical research at several institutions in the USA and UK including: the UCL Institute of Ophthalmology, Moorfields Eye Hospital and the Wilmer Eye Institute.[1][2]
Career
He has specialised in the treatment of glaucoma and in 2005 he established the Glaucoma Research Laboratory at Cambridge.[1] He is also an editor of the Journal of Glaucoma and treasurer of the World Glaucoma Association.[1]
In 2009 he became Cambridge University's Professor of Ophthalmology. This was a new chair, sponsored by the Cambridge Eye Trust.[3] In 2013, he worked with Dr Barbara Lorber and others on the use of a piezoelectric inkjet nozzle to spray ganglion and glial cells from a rat retina.[4] The cells survived the process of deposition in layers and continued to grow in culture. With further development and testing, techniques like this could have clinical application for the repair of damaged retinas.[5][6]
In 2018, Keith became president of the World Glaucoma Association (WGA), the world's largest glaucoma association.
In 2019, Martin moved to Melbourne where he became the Managing Director for the Centre for Eye Research Australia (CERA) and the head of Ophthalmology at the University of Melbourne.
Family life
Keith Martin is married and has three children. He lives in Melbourne.[1] His wife, Susie, is better known as Dr. Susan Harden, the thoracic oncologist and Lead Clinician in Lung Cancer at Addenbrooke Hospital before moving to Australia in late 2019 .[1]
Honours and awards
2010: ARVO Pfizer Ophthalmics Carl Camras Translational Research (TR) Award, or 'ARVO Camras Award for TR'. This is an award for young researchers with innovative work that shows potential for clinical application.[7]
Publications
- Keith Martin (2009), Mechanisms of Retinal Ganglion Cell Death in Glaucoma: New Approaches to the Pathogenesis and Treatment of the Silent Thief of Sight, VDM Publishing, ISBN 9783639161656
See also
References
- ^ a b c d e f g Keith Martin, MA BM BCh DM MRCP FRCOphth ALCM 1980–1987, Head Boy (1986–1987), Royal School, Armagh, retrieved 7 June 2014
- ^ Keith Martin, MA, DM, MRCP, FRCOphth, University of Pittsburgh, 2014
- ^ What We Do, Cambridge Eye Trust, 2012
- ^ Barbara Lorber; Wen-Kai Hsiao; Ian M Hutchings; Keith R Martin (17 December 2013), "Adult rat retinal ganglion cells and glia can be printed by piezoelectric inkjet printing", Biofabrication, 6 (1): 015001, doi:10.1088/1758-5082/6/1/015001, PMID 24345926
- ^ Michelle Roberts (18 December 2013), Scientists 'print' new eye cells, BBC, retrieved 16 June 2014
- ^ "The Man Who Prints Eyeballs", ShortList, 29 May 2014
- ^ Pfizer Ophthalmics Carl Camras Translational Research Awards, ARVO Foundation for Eye Research, 2010, archived from the original on 14 August 2015, retrieved 7 June 2014
External links
- profile at the Department of Clinical Neurosciences